Back to search

Article

ELISL: Early-Late Integrated Synthetic Lethality Prediction in Cancer

2022-09-19

Abstract excerpt

Anti-cancer therapies based on synthetic lethality (SL) exploit tumor vulnerabilities for treatment with reduced side effects. Since simultaneous loss-of-function of SL genes causes cell death, tumors with known gene disruptions can be treated by targeting SL partners. Computational selection of promising SL candidates amongst all gene combinations is key to expedite experimental screening. However, current SL pre...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a35d7faa-13b8-5212-b510-235bfca26c4c
DOI
10.1101/2022.09.19.508413
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ELISL: Early-Late Integrated Synthetic Lethality Prediction in CancerDOI 10.1101/2022.09.19.508413
Select a neighboring publication to make it the new centre.